NCT00712478CompletedNot Applicable
Observational Study on Efficacy of Intensification of Insulin Therapy to at Least 3 Daily Injections in Type 2 Diabetes
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 114
- Primary Endpoint
- Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements
Study Overview
Brief Summary
This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 daily insulin injections, in assessing the proportion of uncontrolled fasting and postprandial glycaemia values recorded on a diary.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 40 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Type 2 diabetes patients
- •Treatment with two insulin daily injections and needing insulin intensification regimen to at least three daily injections
- •HbA1c greater than or equal to 8.0%
Exclusion Criteria
- •Patients not performing glycaemia self-measurements
- •Secondary diabetes
- •Requirement of or use of an insulin pump
- •Treatment with corticoids
Arms & Interventions
A
Intervention: insulin (Drug)
Outcomes
Primary Outcomes
Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements
Time Frame: After 3 months
Secondary Outcomes
- Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements(After first 2 months)
Investigators
Similar Trials
Completed
Not Applicable
Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose ControlDiabetesDiabetes Mellitus, Type 2NCT00700960Novo Nordisk A/S2,745
Completed
Not Applicable
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2NCT00676741Novo Nordisk A/S3,809
Completed
Not Applicable
Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 MonthsDiabetesDiabetes Mellitus, Type 2NCT00755833Novo Nordisk A/S270
Completed
Not Applicable
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2NCT00670722Novo Nordisk A/S6,500
Completed
Not Applicable
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01288326Novo Nordisk A/S254